-
KICVentures acquires Amend Surgical to enhance biologics portfolio: 5 insights
KICVentures acquired Amend Surgical, a company developing synthetic bioactive glass products. -
Cerapedics receives FDA IDE approval for study of P-15L Bone Graft in TLIF surgery: 4 things to know
Orthobiologics company Cerapedics received FDA approval to initiate a study of P-15L Peptide Enhanced Bone Graft compared to autograft in transforaminal lumbar interbody fusion surgery for degenerative disc disease. -
Drs. Kevin Pauza, Gregory Lutz launch study into non-invasive degenerated disc treatment: 5 highlights
Gregory Lutz, MD, and Kevin Pauza, MD, launched a new study to examine the clinical effectiveness of Discseel, a treatment to restore and regrow damaged discs in the spine. -
4 things to know about mesenchymal stromal cells in spine
Mesenchymal stromal cells have shown promise for regenerative medicine, according to the Journal of Orthopaedics. They may improve spinal fusion. -
7 things to know about Dr. Marshall R. Urist, bone morphogenetic protein pioneer
that demineralized bone matrix activity induces bone when implanted ectopically into the muscle or under the skin due to bone morphogenetic proteins. -
Study: use of biologics before or during pregnancy not associated with preterm delivery — 3 insights
The use of biologics before and during pregnancy is not associated with an increased risk of preterm delivery or small-for-gestational-age births, a study in Annals of the Rheumatic Diseases finds. -
MedImmune to create standalone biologics company Viela Bio: 5 things to know
MedImmune will create a standalone company for early-stage inflammatory and autoimmunity biologics. -
Biologics, opioids will be magic words at AAOS 2018 meeting: 5 insights
Surgeons attending the American Academy of Orthopaedic Surgeons 2018 Annual Meeting in New Orleans March 6 to 10 can expect to discuss biologics and opioids, according to Medscape. -
First primate study: stem cells mature into nerve cells in rhesus monkeys with SCI, improve grip — 6 insights
Researchers grafted human spinal cord-derived neural progenitor cells into cervical spinal cord injury sites in rhesus monkeys in a study in Nature Medicine. The human stem cells matured into nerve cells in the monkeys, spurring neuronal connections and improving the monkeys' grip. -
New 3-D printed device enables access to single-cell sequencing, used in HSS study of RA patients: 5 things to know
Researchers at the New York Genome Center and New York University in New York City developed a 3-D printed, portable and low-cost microfluidic device to facilitate access to single-cell sequencing. The researchers used the device to study synovial tissue from patients with rheumatoid arthritis at the New York City-based Hospital for Special Surgery and published their findings in Nature Communications. -
Bioventus, LifeLink to co-develop next generation spine and trauma bone allograft
Bioventus will co-develop a next generation bone allograft solution for spine and trauma surgery with Tampa, Fla.-based LifeLink Tissue Bank. -
Johnson & Johnson, Trinity College Dublin collaborate on new global 3D bioprinting laboratory — 6 insights
Johnson & Johnson is collaborating with Advanced Materials and BioEngineering Research to establish a 3-D bioprinting laboratory. Work on the new laboratory will begin in the first quarter of 2018. -
First patient dosed with non-opioid therapy for OA pain in Centrexion Therapeutics' Phase 3 clinical trial: 4 insights
The first patient in Centrexion Therapeutics Corp.'s Phase 3 VICTORY-1 clinical trial has been dosed with CNTX-4975, a synthetic trans-capsaicin injection for the treatment of chronic moderate to severe pain due to knee osteoarthritis.
Page 35 of 35